Publication | Closed Access

Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients

OncologyPharmacokinetic ModelingTumor ShrinkageMedicineRadiopharmaceutical TherapyBiostatisticsAnti-cancer AgentTime CourseThyroid Cancer PatientsCancer TreatmentPharmacologyCancer GrowthTumor MicroenvironmentCancer ResearchPharmacodynamic Modeling